Document Detail

Increased platelet-activating factor receptor gene expression by corneal epithelial wound healing.
MedLine Citation:
PMID:  10845588     Owner:  NLM     Status:  MEDLINE    
PURPOSE: Platelet activating factor (PAF) is a potent inflammatory mediator the synthesis of which increases in the cornea after injury. The effects of PAF are mediated by receptors (PAF-R), which are present in target cells. This study was undertaken to investigate the effects of wound healing, PAF, and growth factors on modulating PAF-R mRNA levels in corneal epithelial cells. METHODS: Cultures of rabbit corneal epithelial (RCE), rabbit limbal epithelial (RLE), rabbit corneal fibroblast (RCF), and rabbit corneal endothelial (RCEn) cells, as well as rabbit corneal keratocytes (RCKs) were used. For the in vivo wound-healing experiments, a 7-mm central corneal deepithelialization was performed in anesthetized rabbits. For the in vitro experiments, wounded rabbit corneas were maintained in organ culture. Corneas were stimulated with 120 nM PAF or preincubated with PAF antagonists, cyclohexamide (CHX) or actinomycin D (AcD) before adding PAF. RCE cells were stimulated with transforming growth factor (TGF)-beta1, -beta2, and, -beta3, basic fibroblast growth factor (bFGF), keratinocyte growth factor (KGF); and hepatocyte growth factor (HGF). Total RNA was isolated and PAF-R expression evaluated by reverse transcription-polymerase chain reaction (RT-PCR), Northern blot analysis, and quantitative RT-PCR. RESULTS: PAF-R mRNA was expressed in RCE, RLE, and RCEn cells and RCKs, but not in RCFs. After epithelial injury, PAF-R expression increased from 2.5 to 4 times, both in vitro and in vivo. Addition of cPAF further stimulated PAF-R gene expression in epithelium, which was abolished by PAF antagonists. Quantitative RT-PCR revealed that PAF stimulated PAF-R mRNA threefold after injury. The induction of PAF-R by its agonist required previous injury and was inhibited by AcD but not by CHX. Treatment of RCE cells with TGF-beta1, -beta2, or -beta3, HGF, and KGF increased mRNA in PAF-R; however, bFGF had no effect. CONCLUSIONS: Corneal injury produces changes in PAF-R mRNA expression. Whereas stroma fibroblastic cells lost the PAF-R gene expression found in keratocytes, corneal epithelial injury upregulated PAF-R mRNA. These results suggest that activation of selective growth factors and increases in PAF synthesis after injury stimulate PAF-R gene transcription and constitute important feedback mechanisms needed to maintain the inflammatory process and regulate epithelial wound healing.
X Ma; H E Bazan
Related Documents :
21676498 - Association of apoe and lrp mrna levels with dementia and ad neuropathology.
18852838 - Vegf as a target for neuroprotection.
16219308 - Cold-induced expression of the vegf gene in brown adipose tissue is independent of ther...
10918218 - Expression of vascular endothelial growth factor isoforms and their receptors flt-1, kd...
12604608 - Expression of galectin-3 in skeletal tissues is controlled by runx2.
8450048 - Expression of int-2 oncogene in kaposi's sarcoma lesions.
Publication Detail:
Type:  Journal Article; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Investigative ophthalmology & visual science     Volume:  41     ISSN:  0146-0404     ISO Abbreviation:  Invest. Ophthalmol. Vis. Sci.     Publication Date:  2000 Jun 
Date Detail:
Created Date:  2000-06-14     Completed Date:  2000-06-14     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  7703701     Medline TA:  Invest Ophthalmol Vis Sci     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  1696-702     Citation Subset:  IM    
Department of Ophthalmology and Neuroscience Center, Louisiana State University Health Sciences Center, New Orleans, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Blotting, Northern
Cells, Cultured
Cornea / drug effects,  injuries
Epithelium, Corneal / drug effects,  metabolism*
Fibroblast Growth Factor 10
Fibroblast Growth Factor 2 / pharmacology
Fibroblast Growth Factor 7
Fibroblast Growth Factors*
Fibroblasts / drug effects,  metabolism
Gene Expression*
Growth Substances / pharmacology
Hepatocyte Growth Factor / pharmacology
Organ Culture Techniques
Platelet Activating Factor / antagonists & inhibitors,  pharmacology
Platelet Membrane Glycoproteins / biosynthesis,  genetics*
RNA, Messenger / biosynthesis*
Receptors, Cell Surface*
Receptors, G-Protein-Coupled*
Reverse Transcriptase Polymerase Chain Reaction
Transforming Growth Factor beta
Wound Healing*
Grant Support
04928//PHS HHS; EY02377/EY/NEI NIH HHS
Reg. No./Substance:
0/Fibroblast Growth Factor 10; 0/Growth Substances; 0/Platelet Activating Factor; 0/Platelet Membrane Glycoproteins; 0/RNA, Messenger; 0/Receptors, Cell Surface; 0/Receptors, G-Protein-Coupled; 0/Transforming Growth Factor beta; 0/platelet activating factor receptor; 103107-01-3/Fibroblast Growth Factor 2; 126469-10-1/Fibroblast Growth Factor 7; 62031-54-3/Fibroblast Growth Factors; 67256-21-7/Hepatocyte Growth Factor

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Hydrogel lens monomer constituents modulate protein sorption.
Next Document:  Regulation of MMP-9 activity in human tear fluid and corneal epithelial culture supernatant.